Cookie Policy

This site uses cookies to store information on your computer.

I accept the terms and conditions
Skip Ribbon Commands
Skip to main content

 

 

Terumo Acquires Sequent Medical, U.S.-based Developer of New Aneurysm Embolization Device http://www.terumo-europe.com/en-emea/news-articles/Pages/Terumo-Acquires-Sequent-Medical,-US-based-Developer-of-New-Aneurysm-Embolization-Device.aspxTerumo Acquires Sequent Medical, U.S.-based Developer of New Aneurysm Embolization Device Tokyo, Japan13/06/2016 22:00:00
FDA Lifts All Remaining Shipping Restrictions at Terumo Cardiovascular Systems' Ann Arbor Facilityhttp://www.terumo-europe.com/en-emea/news/fda-lifts-all-remaining-shipping-restrictions-at-terumo-cardiovascular-systems-ann-arbor-facilityFDA Lifts All Remaining Shipping Restrictions at Terumo Cardiovascular Systems' Ann Arbor FacilityTokyo, Japan09/06/2016 22:00:00
Major new study investigating abbreviated DAPT post-stent in high bleeding risk patients announcedhttp://www.terumo-europe.com/en-emea/news/major-new-study-investigating-abbreviated-dapt-post-stent-in-high-bleeding-risk-patients-announcedMajor new study investigating abbreviated DAPT post-stent in high bleeding risk patients announcedParis, France17/05/2016 22:00:00

 

 

TOPIC 2016http://www.terumo-europe.com/en-emea/Events/TOPIC 2016.aspxTOPIC 2016Japan20/07/2016 22:00:0023/07/2016 09:05:00Tokyohttp://www.topic.gr.jp/english/, http://www.topic.gr.jp/english/
Workshop on Protein Aggregation and Immunogenicityhttp://www.terumo-europe.com/en-emea/Events/Workshop on Protein Aggregation and Immunogenicity.aspxWorkshop on Protein Aggregation and ImmunogenicityUS01/08/2016 22:00:0004/08/2016 08:41:00Coloradohttps://www.regonline.com/builder/site/Default.aspx?EventID=1809161, https://www.regonline.com/builder/site/Default.aspx?EventID=1809161